{"title":"Do co-formulants influence plant protection product genotoxicity?","authors":"Alkiviadis Stagkos-Georgiadis , Vishal Raolji , Jeannette Koenig , Philip Marx-Stoelting , Sabine Martin , Tewes Tralau , Carsten Kneuer , Alfonsina Paola D'Ambrosio Melendrez , Christian Tobias Willenbockel , Veronika Städele , Tanja Schwerdtle , Denise Bloch","doi":"10.1016/j.yrtph.2026.106059","DOIUrl":null,"url":null,"abstract":"<div><div>Plant protection products (PPPs) contain active substances (AS) providing pesticidal activity and co-formulants supporting efficacy. AS undergo extensive safety assessment, including genotoxicity testing, while PPPs are assessed only for acute and local toxicity. Genotoxicity may contribute to long-term effects like carcinogenesis, and as operators are exposed to concentrated PPPs and spray dilutions, co-formulant toxicity and interactions require attention. An <em>in silico</em> analysis was conducted to identify potentially genotoxic co-formulants and prioritise PPPs for <em>in vitro</em> testing. Four prioritised co-formulants exceeded 1 % concentration in eight PPPs, but existing data ruled out further investigation. AS with known <em>in vitro</em> genotoxic potential were assessed for toxicokinetic interaction with co-formulants. The genotoxic potential of PPPs containing metiram, a dithiocarbamate fungicide, and pendimethalin, a dinitroaniline herbicide, was assessed in V79 cells using <em>in vitro</em> micronucleus test. No difference was observed between metiram and its PPP, whereas a 2-fold increase in micronuclei formation occurred in formulated PPP compared to pendimethalin alone at highest tested concentration. These findings indicate that co-formulants, although unlikely to be genotoxic on their own, may influence the genotoxic potential of pendimethalin in the tested PPP. Therefore, AS showing genotoxic potential <em>in vitro</em> should be considered for testing in respective formulated PPPs.</div></div>","PeriodicalId":20852,"journal":{"name":"Regulatory Toxicology and Pharmacology","volume":"167 ","pages":"Article 106059"},"PeriodicalIF":4.3000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regulatory Toxicology and Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0273230026000322","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, LEGAL","Score":null,"Total":0}
引用次数: 0
Abstract
Plant protection products (PPPs) contain active substances (AS) providing pesticidal activity and co-formulants supporting efficacy. AS undergo extensive safety assessment, including genotoxicity testing, while PPPs are assessed only for acute and local toxicity. Genotoxicity may contribute to long-term effects like carcinogenesis, and as operators are exposed to concentrated PPPs and spray dilutions, co-formulant toxicity and interactions require attention. An in silico analysis was conducted to identify potentially genotoxic co-formulants and prioritise PPPs for in vitro testing. Four prioritised co-formulants exceeded 1 % concentration in eight PPPs, but existing data ruled out further investigation. AS with known in vitro genotoxic potential were assessed for toxicokinetic interaction with co-formulants. The genotoxic potential of PPPs containing metiram, a dithiocarbamate fungicide, and pendimethalin, a dinitroaniline herbicide, was assessed in V79 cells using in vitro micronucleus test. No difference was observed between metiram and its PPP, whereas a 2-fold increase in micronuclei formation occurred in formulated PPP compared to pendimethalin alone at highest tested concentration. These findings indicate that co-formulants, although unlikely to be genotoxic on their own, may influence the genotoxic potential of pendimethalin in the tested PPP. Therefore, AS showing genotoxic potential in vitro should be considered for testing in respective formulated PPPs.
期刊介绍:
Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.
Types of peer-reviewed articles published:
-Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:
1.Factors influencing human sensitivity
2.Exposure science related to risk assessment
3.Alternative toxicological test methods
4.Frameworks for evaluation and integration of data in regulatory evaluations
5.Harmonization across regulatory agencies
6.Read-across methods and evaluations
-Contemporary Reviews on policy related Research issues
-Letters to the Editor
-Guest Editorials (by Invitation)